Article Information
History
- August 24, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Cynthia Bernal1,
- Sara Ping2,
- Alejandra Rojas1,
- Oliver Caballero1,
- Victoria Stittleburg2,
- Yvalena de Guillén1,
- Patricia Langjahr3,
- Benjamin A. Pinsky4,5,
- Marta Von-Horoch6,
- Patricia Luraschi6,
- Sandra Cabral6,
- María Cecilia Sánchez7,
- Aurelia Torres7,
- Fátima Cardozo1,7 and
- Jesse J. Waggoner2,8,*
- 1Universidad Nacional de Asunción, Instituto de Investigaciones en Ciencias de la Salud, San Lorenzo, Paraguay
- 2Emory University School of Medicine, Division of Infectious Diseases, Atlanta, GA, USA
- 3Universidad Nacional de Asunción, Facultad de Ciencias Químicas, San Lorenzo, Paraguay
- 4Department of Pathology, Stanford University School of Medicine, California, USA
- 5Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, California, USA
- 6Hospital Central - Instituto de Previsión Social, Departamento de Epidemiología, Asunción, Paraguay
- 7Hospital Central - Instituto de Previsión Social, Departamento de Laboratorio de Análisis Clínicos, Asunción, Paraguay
- 8Rollins School of Public Health, Department of Global Health, Atlanta, GA, USA
- ↵*Corresponding author; email: jjwaggo{at}emory.edu
Posted August 24, 2022.
Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue
